USC.edu
Are You a Patient?

Neha Nanda, MD

Clinical Professor of Medicine (Clinician Educator), Hospital Epidemiologist and Medical Director of Antimicrobial Stewardship at Keck Medicine of USC, Chief of Infectious Diseases

Image of Neha Nanda, MD
Is this your profile? Click to edit
Email [email protected]
CTSI Profile

Overview

Dr. Nanda heads Healthcare Epidemiology/Infection Prevention and Antimicrobial Stewardship at Keck Medicine of USC and its affiliated hospitals and clinics. In this capacity, she leads Keck Medicine’s preparation and response for emerging infectious disease. In the last year, through the pandemic, she has led protocol and guideline development as it relates to patient and healthcare safety. Her research interests are geared towards infection prevention strategies and emerging pathogens. Her select publications include the impact of a multidisciplinary approach in reducing preventable harm, treatment strategies and diagnostics for C. difficile and biomarkers for appropriate antimicrobial use.

Awards

  • Society of Healthcare and Epidemiology of America: Jonathan Freeman Scholarship for Excellence in Healthcare Epidemiology Research, 2007
  • Yale University: William Wirt Winchester Research Fund Award for Tuberculosis Research, 2007
  • Yale University: Yale Infectious Diseases Collaborative Fund, 2007
  • Waterbury Hospital: In the Spotlight Award for Recognition of Efforts for Ebola Preparedness, 2015

Publications

  • Predicting clinical outcomes in COVID-19 using radiomics on chest radiographs. Br J Radiol. 2021 Oct 01; 94(1126):20210221.. View in PubMed
  • Frame to Improve the Fit of N95 Filtering Face Mask Respirators. J Occup Environ Med. 2021 Jun 01; 63(6):e362-e366.. View in PubMed
  • The time to offer treatments for COVID-19. Expert Opin Investig Drugs. 2021 May; 30(5):505-518.. View in PubMed
  • Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer. Pancreatology. 2021 Aug; 21(5):938-941.. View in PubMed
  • Machine learning based predictors for COVID-19 disease severity. Sci Rep. 2021 02 25; 11(1):4673.. View in PubMed
  • The Importance of Understanding the Stages of COVID-19 in Treatment and Trials. AIDS Rev. 2021 02 08; 23(1):40-47.. View in PubMed
  • A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population. J Adolesc Health. 2020 12; 67(6):763-768.. View in PubMed
  • Clostridium difficile disease in solid organ transplant recipients: a recommended treatment paradigm. Curr Opin Organ Transplant. 2020 08; 25(4):357-363.. View in PubMed
  • Prevalence of Germline Mutations Associated With Cancer Risk in Patients With Intraductal Papillary Mucinous Neoplasms. Gastroenterology. 2019 05; 156(6):1905-1913.. View in PubMed
  • GDH and toxin immunoassay for the diagnosis of Clostridioides (Clostridium) difficile infection is not a ‘one size fit all’ screening test. Diagn Microbiol Infect Dis. 2019 Jun; 94(2):109-112.. View in PubMed

Similar People